| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8537269 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2018 | 27 Pages |
Abstract
Two months of OROS-MPH treatment decreased DAT availability in both the right caudate and putamen. Adolescents with ADHD who showed a robust response to OROS-MPH had greater reduction of DAT density in the right putamen. However,our findings did not support an association between homozygosity for a 10-repeat allele in the DAT1 gene and DAT density, assessedusing[Tc-99m] TRODAT-1SPECT.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
![Genetic imaging study with [Tc-99m] TRODAT-1 SPECT in adolescents with ADHD using OROS-methylphenidate](/preview/png/8537269.png "First Page Preview: Genetic imaging study with [Tc-99m] TRODAT-1 SPECT in adolescents with ADHD using OROS-methylphenidate")
Authors
Aynur Pekcanlar Akay, Gamze Ãapa Kaya, Samet Kose, ÃiÄdem Eresen YazıcıoÄlu, Handan Ãzek Erkuran, Sevay AlÅen Güney, Kaya OÄuz, Duygu Keskin, Burak Baykara, Neslihan Ä°nal EmiroÄlu, Mine Åencan Eren, Sefa KızıldaÄ, Türkan Ertay,